Charles Schwab’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Buy |
553,081
+17,237
| +3% | +$351K | ﹤0.01% | 1956 |
|
|
2025
Q1 | $9.73M | Sell |
535,844
-8,486
| -2% | -$154K | ﹤0.01% | 1967 |
|
|
2024
Q4 | $13.8M | Buy |
544,330
+5,474
| +1% | +$138K | ﹤0.01% | 1878 |
|
|
2024
Q3 | $18.3M | Buy |
538,856
+8,413
| +2% | +$286K | ﹤0.01% | 1738 |
|
|
2024
Q2 | $19.6M | Buy |
530,443
+31,222
| +6% | +$1.16M | ﹤0.01% | 1693 |
|
|
2024
Q1 | $21M | Buy |
499,221
+89,830
| +22% | +$3.77M | ﹤0.01% | 1580 |
|
|
2023
Q4 | $16.2M | Buy |
409,391
+47,844
| +13% | +$1.9M | ﹤0.01% | 1714 |
|
|
2023
Q3 | $9.95M | Buy |
361,547
+10,818
| +3% | +$298K | ﹤0.01% | 1908 |
|
|
2023
Q2 | $11.9M | Buy |
350,729
+4,006
| +1% | +$136K | ﹤0.01% | 1828 |
|
|
2023
Q1 | $12.5M | Sell |
346,723
-1,530
| -0.4% | -$55K | ﹤0.01% | 1758 |
|
|
2022
Q4 | $15.5M | Buy |
348,253
+10,722
| +3% | +$478K | 0.01% | 1599 |
|
|
2022
Q3 | $9.49M | Buy |
337,531
+6,972
| +2% | +$196K | ﹤0.01% | 1870 |
|
|
2022
Q2 | $8.91M | Sell |
330,559
-6,249
| -2% | -$168K | ﹤0.01% | 1901 |
|
|
2022
Q1 | $11.5M | Buy |
336,808
+8,713
| +3% | +$297K | ﹤0.01% | 1877 |
|
|
2021
Q4 | $12.7M | Buy |
328,095
+5,639
| +2% | +$218K | ﹤0.01% | 1875 |
|
|
2021
Q3 | $17.4M | Buy |
322,456
+224,831
| +230% | +$12.1M | 0.01% | 1690 |
|
|
2021
Q2 | $3.27M | Buy |
97,625
+83,116
| +573% | +$2.78M | ﹤0.01% | 2554 |
|
|
2021
Q1 | $299K | Hold |
14,509
| – | – | ﹤0.01% | 3244 |
|
|
2020
Q4 | $255K | Sell |
14,509
-2,072
| -12% | -$36.4K | ﹤0.01% | 3221 |
|
|
2020
Q3 | $246K | Buy |
+16,581
| New | +$246K | ﹤0.01% | 3110 |
|
|
2018
Q2 | – | Sell |
-38,263
| Closed | -$1.34M | – | 3118 |
|
|
2018
Q1 | $1.34M | Sell |
38,263
-5,823
| -13% | -$204K | ﹤0.01% | 2437 |
|
|
2017
Q4 | $1.88M | Buy |
44,086
+6,012
| +16% | +$256K | ﹤0.01% | 2331 |
|
|
2017
Q3 | $1.63M | Sell |
38,074
-1,918
| -5% | -$82.3K | ﹤0.01% | 2355 |
|
|
2017
Q2 | $1.48M | Buy |
39,992
+5,990
| +18% | +$222K | ﹤0.01% | 2331 |
|
|
2017
Q1 | $1.84M | Buy |
34,002
+6,369
| +23% | +$345K | ﹤0.01% | 2228 |
|
|
2016
Q4 | $1.47M | Buy |
27,633
+1,350
| +5% | +$71.7K | ﹤0.01% | 2301 |
|
|
2016
Q3 | $1.59M | Buy |
26,283
+3,673
| +16% | +$223K | ﹤0.01% | 2241 |
|
|
2016
Q2 | $1.49M | Buy |
22,610
+1,294
| +6% | +$85.2K | ﹤0.01% | 2196 |
|
|
2016
Q1 | $1.21M | Sell |
21,316
-600
| -3% | -$34K | ﹤0.01% | 2265 |
|
|
2015
Q4 | $5.16M | Buy |
21,916
+1,187
| +6% | +$279K | 0.01% | 1502 |
|
|
2015
Q3 | $3.28M | Buy |
20,729
+405
| +2% | +$64K | ﹤0.01% | 1755 |
|
|
2015
Q2 | $7.69M | Buy |
20,324
+1,739
| +9% | +$658K | 0.01% | 1237 |
|
|
2015
Q1 | $7.77M | Buy |
18,585
+1,345
| +8% | +$562K | 0.01% | 1185 |
|
|
2014
Q4 | $4.72M | Buy |
17,240
+989
| +6% | +$271K | 0.01% | 1491 |
|
|
2014
Q3 | $3.16M | Buy |
16,251
+586
| +4% | +$114K | 0.01% | 1701 |
|
|
2014
Q2 | $3.84M | Sell |
15,665
-62
| -0.4% | -$15.2K | 0.01% | 1592 |
|
|
2014
Q1 | $4.17M | Buy |
15,727
+697
| +5% | +$185K | 0.01% | 1476 |
|
|
2013
Q4 | $5.46M | Buy |
15,030
+1,781
| +13% | +$647K | 0.01% | 1176 |
|
|
2013
Q3 | $7.52M | Buy |
13,249
+541
| +4% | +$307K | 0.02% | 821 |
|
|
2013
Q2 | $3.12M | Buy |
+12,708
| New | +$3.12M | 0.01% | 1431 |
|